The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer ; volume:5 ; number:1 ; day:18 ; month:10 ; year:2016 ; pages:1-8 ; date:12.2016
SpringerPlus ; 5, Heft 1 (18.10.2016), 1-8, 12.2016
- Creator
-
Shibutani, Masatsune
- Contributor
-
Maeda, Kiyoshi
Nagahara, Hisashi
Iseki, Yasuhito
Hirakawa, Kosei
Ohira, Masaichi
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-3529-y
- URN
-
urn:nbn:de:101:1-2018072021462928009748
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Shibutani, Masatsune
- Maeda, Kiyoshi
- Nagahara, Hisashi
- Iseki, Yasuhito
- Hirakawa, Kosei
- Ohira, Masaichi
- SpringerLink (Online service)
Other Objects (12)
The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
C-Reactive Protein-to-Albumin Ratio as a Prognostic Inflammatory Marker in COVID-19
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury
Predictive value of postoperative C-reactive protein-to-albumin ratio in anastomotic leakage after esophagectomy
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
Preoperative C-reactive protein to albumin ratio and oral health in oral squamous cell carcinoma patients
The predictive value of the C-reactive protein/albumin ratio in adult patients with complicated appendicitis
C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Critically Ill Pediatric Patients
Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis
The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
C-Reactive Protein-to-Albumin Ratio as a Prognostic Inflammatory Marker in COVID-19
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury
Predictive value of postoperative C-reactive protein-to-albumin ratio in anastomotic leakage after esophagectomy
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
Preoperative C-reactive protein to albumin ratio and oral health in oral squamous cell carcinoma patients
The predictive value of the C-reactive protein/albumin ratio in adult patients with complicated appendicitis
C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Critically Ill Pediatric Patients
Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis
The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
Author Correction: C-reactive protein/albumin ratio is the most significant inflammatory marker in unresectable pancreatic cancer treated with FOLFIRINOX or gemcitabine plus nab-paclitaxel
C-Reactive Protein-to-Albumin Ratio as a Prognostic Inflammatory Marker in COVID-19
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
Prognostic value of C-reactive protein to albumin ratio for mortality in acute kidney injury
Predictive value of postoperative C-reactive protein-to-albumin ratio in anastomotic leakage after esophagectomy
The C-reactive protein/albumin ratio predicts overall survival of patients with advanced pancreatic cancer
Preoperative C-reactive protein to albumin ratio and oral health in oral squamous cell carcinoma patients
The predictive value of the C-reactive protein/albumin ratio in adult patients with complicated appendicitis
C-Reactive Protein/Albumin Ratio as an Independent Predictor of Mortality in Critically Ill Pediatric Patients